Get started Log in

IBT B — Infant Bacterial Therapeutics AB Share News

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall CapMomentum Trap

Market Cap
SEK1.12bn
Enterprise Value
SEK1.01bn
Revenue

Brief: Infant Bacterial Therapeutics Starts Listing On Nasdaq Stockholm Main Market On Sept 10
30/08/2018 09:31
Swedish stocks: Seen opening higher, ICA Q2 EBIT misses consensus
16/08/2018 07:43
Brief: Infant Bacterial Therapeutics AB Operating Profit at SEK 1.3 MLN
16/08/2018 07:08
Brief: Infant Bacterial Therapeutics Jan-March Operating Loss Slightly Widens To SEK 9.1 Million
15/05/2018 07:07
Brief: Infant Bacterial Therapeutics Q4 Operating Loss Narrows To Sek 9.1 Mln
28/02/2018 07:11
Brief: IBT Raises About SEK 440 Million In Rights Issue
02/02/2018 11:00
Brief: Infant Bacterial Therapeutics announces capital raise
24/11/2017 07:00
Brief: Infant Bacterial Therapeutics Q3 operating loss narrows to SEK 4.6 mln
23/11/2017 07:33
Brief: EMA adopts positive opinion on paediatric investigation plan for IBT's lead product
28/09/2017 07:31
Brief: Infant Bacterial Therapeutics Q2 oper loss at SEK 13.8 mln
28/08/2017 07:05
Brief: Infant Bacterial Therapeutics Jan-Mar operating loss widens to SEK 8.6 mln
04/05/2017 11:02
Brief: Infant Bacterial Therapeutics H2 operating loss widens to SEK 22.0 mln
14/02/2017 07:06
Brief: Infant Bacterial Therapeutics appoints Daniel Mackey new CFO
12/10/2016 09:45
Brief: Infant Bacterial Therapeutics H1 operating loss widening to SEK 16.1 mln
19/08/2016 07:15
Brief: Infant Bacterial Therapeutics rights issue fully subscribed
26/05/2016 07:10